Notably, in this study, IDO1 expression was significantly reduced in tumors from mice treated with PTSO-pretreated hPBMCs, suggesting that this organosulfur compound may mitigate immune suppression and enhance anti-tumor immune responses, ultimately promoting tumor immunogenic cell death [25]. The gene discussed is IDO1; the disease is neoplasm.